Advisory Services Network, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1573876
Atlanta, GA
Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,913,344
-$175,763 QoQ
Shares Held
6,356
+0.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#334
of 784 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Derivatives in ALNY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$602,060
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisory Services Network, LLC holds $28,927,722 across 25 Biotechnology names. ALNY ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
51,566 | $5,845,518 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,289 | $2,674,357 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,141 | $2,553,682 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
230,454 | $2,263,058 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
6,356 | $1,913,344 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
17,371 | $1,415,907 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,135 | $1,409,315 | |
| 8 | EXEL |
Exelixis, Inc.
|
20,558 | $1,118,559 |
All Filings in ALNY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,913,344 | 6,356 | Shares | Other | 2026-08-12 | |
| 2026-06-30 | $602,060 | 2,000 | Put | Sole | 2026-08-12 | |
| 2026-03-31 | $2,089,107 | 6,314 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,218,179 | 8,093 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,194,736 | 7,006 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $2,091,865 | 6,415 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $3,649,589 | 13,516 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,474,922 | 6,268 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,806,671 | 6,569 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,596,267 | 6,569 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $57,231 | 299 | Shares | Sole | 2024-02-09 | |
| 2023-03-31 | $54,686 | 273 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $196,536 | 827 | Shares | Sole | 2023-02-13 | |
| 2021-06-30 | $8,476 | 50 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $6,498 | 50 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $28,683 | 197 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $4,789 | 44 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||